It has been tough sledding for fans of dividend stocks lately, but the latest economic news could help to smooth out the ride. Long-term bond yields have tumbled as a result, which should be good news ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial cancer in adults.

London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy ...

European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...

The European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for ...

GSK plc (LSE/NYSE: GSK) today announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

European regulators have expanded the usage of GSK's Jemperli drug for endometrial cancer, the pharmaceutical firm announced ...

A recent SBI report has stirred the proverbial hornet’s nest with its claims of a sharp reduction in India’s poverty levels, ...

The NSS surveys use the modified mixed reference period (MMRP) from 2011-12, and the earlier method of mixed reference period (MRP) is not used in the surveys conducted in 2022-23 and 2023-24,. The ...

The NSSO has since changed its methods for measuring household consumption, moving from the Mixed Reference Period (MRP) to the Modified Mixed Reference Period (MMRP), affecting comparability. The ...

The NSSO has since changed its methods for measuring household consumption, moving from the Mixed Reference Period (MRP) to the Modified Mixed Reference Period (MMRP), affecting comparability.